Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person13
Immunome Inc.
Company
IMMUNIC, INC.
Company
Immunovant, Inc.
Company
Imunon, Inc.
Company
AIM ImmunoTech Inc.
Company
ImmunityBio, Inc.
Company
CERENOME, INC.
Company
Freenome, Inc.
Company
Altimmune, Inc.
Company
Lyell Immunopharma, Inc.
Company
Estrella Immunopharma, Inc.
Company
Evommune, Inc.
Company
Autohome Inc.
Company
Primary record8
Immunome Inc. filed SCHEDULE 13G
0002100119-26-001633.txt : 20261030 SCHEDULE 13G 1 primary_doc.xml X0202 SCHEDULE 13G 0002100119 XXXXXXXX LIVE Common Stock 09/30/2026 0001472012 Immunome Inc 45257U108 18702 North Creek Parkway Suite 100 Bothell WA 9801
Immunome Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Amendment to License Agreement On October 2, 2026, Immunome, Inc. (the Company ) entered into Amendment No. 4 to License Agreement (the Amendment ) with Bristol-Myers
Immunome Inc. filed 4
SEC form 4 filed by Immunome Inc. (CIK 1472012) on 2026-09-15.
Immunome Inc. filed SCHEDULE 13G/A
0001897612-26-000609.txt : 20260814 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001897612-25-000510 0001897612 XXXXXXXX LIVE 2 COMMON STOCK 06/30/2026 0001472012 IMMUNOME INC 45257U108 18702 N. CREEK PARKWAY S
Immunome Inc. filed SCHEDULE 13G/A
, the beneficial owner of the securities reported herein. The address of the principal business office of Sirenia and Mr. Silverstein is 1674 Meridian Avenue, Suite 320, Miami Beach, FL 33139. Sirenia is a Delaware limit
Immunome Inc. filed 4
SEC form 4 filed by Immunome Inc. (CIK 1472012) on 2026-08-12.
Immunome Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On August 11, 2026, Immunome, Inc. (the “Company”) announced its financial results for the second quarter ended June 30, 2026 and provided a business update in the
Immunome Inc. filed 4
SEC form 4 filed by Immunome Inc. (CIK 1472012) on 2026-08-10.